CoinScoopSEC Receives Amended S-1/A Filing for 21Shares Injective ETF
The U.S. SEC has received an amended S-1/A registration statement for the 21Shares Injective ETF, updating an original filing from October 2025. If approved, the ETF will trade on Nasdaq under the ticker TINJ, tracking the FTSE Injective Index and potentially staking a portion of its holdings to generate yield. This move follows 21Shares' previous launch of an Injective staking ETP in Europe.
Summaries are written by AI from the original article. Not investment advice.